Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Nanomaterial Delivery Systems for mRNA VaccinesVaccines (Basel), 2021-01, Vol.9 (1), p.65 [Peer Reviewed Journal]2021. This work is licensed under http://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 by the authors. 2021 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines9010065 ;PMID: 33478109Full text available |
|
2 |
Material Type: Article
|
Efforts at COVID-19 Vaccine Development: Challenges and SuccessesVaccines (Basel), 2020-12, Vol.8 (4), p.739 [Peer Reviewed Journal]2020. This work is licensed under http://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 by the authors. 2020 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines8040739 ;PMID: 33291245Full text available |
|
3 |
Material Type: Article
|
Challenges of Storage and Stability of mRNA-Based COVID-19 VaccinesVaccines (Basel), 2021-09, Vol.9 (9), p.1033 [Peer Reviewed Journal]2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 by the authors. 2021 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines9091033 ;PMID: 34579270Full text available |
|
4 |
Material Type: Article
|
Immune-Mediated Disease Flares or New-Onset Disease in 27 Subjects Following mRNA/DNA SARS-CoV-2 VaccinationVaccines (Basel), 2021-04, Vol.9 (5), p.435 [Peer Reviewed Journal]2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 by the authors. 2021 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines9050435 ;PMID: 33946748Full text available |
|
5 |
Material Type: Article
|
Safety and Immunogenicity of the Third Booster Dose with Inactivated, Viral Vector, and mRNA COVID-19 Vaccines in Fully Immunized Healthy Adults with Inactivated VaccineVaccines (Basel), 2022-01, Vol.10 (1), p.86 [Peer Reviewed Journal]2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2022 by the authors. 2022 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines10010086 ;PMID: 35062747Full text available |
|
6 |
Material Type: Article
|
Emerging SARS-CoV-2 Variants and Impact in Global Vaccination Programs against SARS-CoV-2/COVID-19Vaccines (Basel), 2021-03, Vol.9 (3), p.243 [Peer Reviewed Journal]2021. This work is licensed under http://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 by the authors. 2021 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines9030243 ;PMID: 33799505Full text available |
|
7 |
Material Type: Article
|
Progress and Prospects on Vaccine Development against SARS-CoV-2Vaccines (Basel), 2020-03, Vol.8 (2), p.153 [Peer Reviewed Journal]2020. This work is licensed under http://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 by the authors. 2020 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines8020153 ;PMID: 32235387Full text available |
|
8 |
Material Type: Article
|
Evaluation of Side Effects Associated with COVID-19 Vaccines in Saudi ArabiaVaccines (Basel), 2021-06, Vol.9 (6), p.674 [Peer Reviewed Journal]2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 by the authors. 2021 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines9060674 ;PMID: 34207394Full text available |
|
9 |
Material Type: Article
|
Role of Inflammatory Cytokines in COVID-19 Patients: A Review on Molecular Mechanisms, Immune Functions, Immunopathology and Immunomodulatory Drugs to Counter Cytokine StormVaccines (Basel), 2021-04, Vol.9 (5), p.436 [Peer Reviewed Journal]2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 by the authors. 2021 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines9050436 ;PMID: 33946736Full text available |
|
10 |
Material Type: Article
|
Attitude and Behaviors towards SARS-CoV-2 Vaccination among Healthcare Workers: A Cross-Sectional Study from PolandVaccines (Basel), 2021-03, Vol.9 (3), p.218 [Peer Reviewed Journal]2021. This work is licensed under http://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 by the authors. 2021 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines9030218 ;PMID: 33806641Full text available |
|
11 |
Material Type: Article
|
Waning of IgG, Total and Neutralizing Antibodies 6 Months Post-Vaccination with BNT162b2 in Healthcare WorkersVaccines (Basel), 2021-09, Vol.9 (10), p.1092 [Peer Reviewed Journal]2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 by the authors. 2021 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines9101092 ;PMID: 34696200Full text available |
|
12 |
Material Type: Article
|
Willingness to Receive the Booster COVID-19 Vaccine Dose in PolandVaccines (Basel), 2021-11, Vol.9 (11), p.1286 [Peer Reviewed Journal]2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 by the authors. 2021 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines9111286 ;PMID: 34835217Full text available |
|
13 |
Material Type: Article
|
COVID-19 Vaccine Booster Hesitancy (VBH) of Healthcare Workers in Czechia: National Cross-Sectional StudyVaccines (Basel), 2021-12, Vol.9 (12), p.1437 [Peer Reviewed Journal]2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 by the authors. 2021 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines9121437 ;PMID: 34960183Full text available |
|
14 |
Material Type: Article
|
Emerging SARS-CoV-2 Variants: A Review of Its Mutations, Its Implications and Vaccine EfficacyVaccines (Basel), 2021-10, Vol.9 (10), p.1195 [Peer Reviewed Journal]2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 by the authors. 2021 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines9101195 ;PMID: 34696303Full text available |
|
15 |
Material Type: Article
|
Attitudes and Beliefs on Influenza Vaccination during the COVID-19 Pandemic: Results from a Representative Italian SurveyVaccines (Basel), 2020-11, Vol.8 (4), p.711 [Peer Reviewed Journal]2020. This work is licensed under http://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 by the authors. 2020 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines8040711 ;PMID: 33266212Full text available |
|
16 |
Material Type: Article
|
Biological Properties of SARS-CoV-2 Variants: Epidemiological Impact and Clinical ConsequencesVaccines (Basel), 2022-06, Vol.10 (6), p.919 [Peer Reviewed Journal]2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2022 by the authors. 2022 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines10060919 ;PMID: 35746526Full text available |
|
17 |
Material Type: Article
|
Reactivation of Varicella Zoster Virus after Vaccination for SARS-CoV-2Vaccines (Basel), 2021-06, Vol.9 (6), p.572 [Peer Reviewed Journal]2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 by the authors. 2021 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines9060572 ;PMID: 34205861Full text available |
|
18 |
Material Type: Article
|
Medical Students and SARS-CoV-2 Vaccination: Attitude and BehaviorsVaccines (Basel), 2021-02, Vol.9 (2), p.128 [Peer Reviewed Journal]2021. This work is licensed under http://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 by the authors. 2021 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines9020128 ;PMID: 33562872Full text available |
|
19 |
Material Type: Article
|
Comparison of Four SARS-CoV-2 Neutralization AssaysVaccines (Basel), 2020-12, Vol.9 (1), p.13 [Peer Reviewed Journal]2021. This work is licensed under http://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 by the authors. 2020 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines9010013 ;PMID: 33379160Full text available |
|
20 |
Material Type: Article
|
COVID-19 Vaccine Boosters: The Good, the Bad, and the UglyVaccines (Basel), 2021-11, Vol.9 (11), p.1299 [Peer Reviewed Journal]2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 by the authors. 2021 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines9111299 ;PMID: 34835230Full text available |